Oxygen Biotherapeutics, US Navy to study Oxycyte for treatment of hemorrhagic shock

07:22 EDT 3 Aug 2012 | Pharmaceutical Business Review

Oxygen Biotherapeutics, a development stage biomedical company, has signed a cooperative research and development agreement (CRADA) with the Naval Medical Research Unit of San Antonio (NAMRU-SA) in the US to study Oxycyte for treatment of hemorrhagic..

Original Article: Oxygen Biotherapeutics, US Navy to study Oxycyte for treatment of hemorrhagic shock

More From BioPortfolio on "Oxygen Biotherapeutics, US Navy to study Oxycyte for treatment of hemorrhagic shock"

Biotech & Healthcare Channels World News Life Science Events Corporate Database Market Reports Categories

Search BioPortfolio:

Clinical Trials - Daily Updated Database search the latest medical and pharmaceutical trials.

Drugs Database search our comprehensive database of prescription drugs.

Research Literature - Daily Updated Database search biomedical papers and journals.

News Quicklinks

Search Biotech, Medical and Healthcare News

Biotech News by Article Type

Biotech News by Location

BioPortfolio Bloggers

Publishing Your News on BioPortfolio

Recent Visitor News Searches

Searches Linking to this Story

oxygen biotherapeutics navy, oxycyte

Latest Biotechnology, Pharmaceutical and Healthcare News

Feds Make It Easier For States To Enroll Poor Under Health Law

Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Case Management Conference in New Jersey Ethicon Pelvic Mesh Litigation

Registration Open for Fifth Annual Step Up for Cancer Event

hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer

hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announce the Best Weight Loss Through New Whole Foods, Healthy Snacks and Prescription Strength hCG Treatments

Bel Marra Health Reports on a New Study Revealing a New Approach to Reverse Aging

Doctors Health Press Reports on Study: Mathematical Formula May Better Predict the Effectiveness of a Patient’s Treatment Than That Patient’s Doctor

BioPortfolio Limited

Publish Content

Agreements

Tools

Help

This site complies with the HONcode standard for trustworthy health information:
Verify here.

The information provided by BioPortfolio.com is not a substitute for professional medical advice, diagnosis or treatment. The BioPortfolio site is sponsored BioPortfolio Limited with offices at Stafford House, 10 Prince of Wales Road, Dorchester, DT1 1PW, England. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of “Fair Use” and legitimately infringes on your or your client's copyright we may be contacted concerning copyright matters at: priority@bioportfolio.com.
All rights reserved. All other trademarks recognized. Copyright © 1997-2013 BioPortfolio Limited. Site developed by Alacrify Ltd.